Company news
Palatin Technologies, Inc. (AMEX:PTN) news
Palatin Technologies, Inc. news releases on 6ix. Latest, May 18, 2026: Palatin to Begin Trading on Nasdaq Stock Exchange
Press releases & updates
Palatin to Begin Trading on Nasdaq Stock Exchange
May 18, 2026
Palatin Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
May 13, 2026
Palatin Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update
February 17, 2026
Palatin Technologies Announces Closing of Upsized $18.2 Million Public Offering with the Full Exercise of the Underwriters' Over-Allotment Option
November 12, 2025
Palatin Reports Fiscal Year 2025 Third Quarter Results and Business Update
May 14, 2025
Palatin Presents Promising Preclinical Data on Melanocortin Agonists for Retinopathy at ARVO 2025
May 9, 2025
Palatin Presents Breakthrough Symptom Resolution Data from Phase 3 PL9643 MELODY-1 Clinical Trial in Dry Eye Disease at ARVO 2025
May 8, 2025
Palatin Technologies Announces Closing of Reduced Public Offering
May 7, 2025
Palatin Expects $11.5 Million Financing to Cure NYSE American Delisting Notice
May 7, 2025
Palatin Technologies Announces Pricing of up to $23 Million Public Offering
May 7, 2025
Palatin Technologies Announces Transition to OTC Pink Following NYSE American Delisting Notice
May 6, 2025
Palatin Presents Promising Preclinical Data for Melanocortin Agonist PL9588 at ARVO 2025, Highlighting a Dual-Action Glaucoma Therapy
May 5, 2025
Palatin Announces Breakthrough Symptom Resolution in Updated Analyses from Phase 3 PL9643 MELODY-1 Clinical Trial in Dry Eye Disease
April 29, 2025